(Press-News.org)
University of Virginia School of Medicine researchers have revealed how the popular, low-carb ketogenic diet protects against epilepsy seizures and possibly neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
Keto, as the diet is commonly known, has been used to reduce seizures in patients with medication-resistant epilepsy since the 1920s. Doctors, however, have been uncertain exactly how the diet does this, even as they identified potential benefits for other brain disorders.
A team led by UVA’s Jaideep Kapur, MBBS, PhD, co-director of UVA’s Brain Institute, has found answers. This discovery could eventually allow patients to reap the benefits of the keto diet without the highly restrictive eating – almost devoid of sweet treats and comforting carbohydrates – necessary to stay “in keto.”
“The body converts the keto diet to a ketone body called β-hydroxybutyrate. We discovered that HCAR2 helps β-hydroxybutyrate reduce seizures by regulating the activity and communication of brain cells,” said Kapur, an epileptologist (epilepsy expert) at UVA Health and the School of Medicine’s Department of Neurology and Neuroscience. “Many individuals are unable to tolerate the keto diet due to high fat content and side effects. This discovery helps find drugs that have the beneficial effects of the keto diet. Niacin, an FDA-approved lipid-lowering drug, also works on HCAR2.”
Keto Diet Brain Benefits
The keto diet aims to encourage our bodies to burn fat instead of carbohydrates for fuel. This can provide obvious benefits for those trying to lose weight, but it also causes unseen changes in the body, and many people cannot tolerate such a high-fat diet. Keto prompts our livers to produce molecules called ketones (ketosis), which replace easily burned carbohydrates as fuel for our brain cells.
Kapur, researcher Soudabeh Naderi and their colleagues found that one of the most common of these ketones, β-hydroxybutyrate, interacts with a specific cellular receptor to reduce seizures in lab mice. It does this by calming nerve cells called neurons, the scientists found. When neurons become too excitable, they can trigger seizures. Hyperactive neurons are also seen in early Alzheimer’s and in other conditions, such as autism.
As part of their research, Kapur and his team mapped out the receptor’s presence in the hippocampus, the portion of the brain where seizures often begin. They found the receptor, hydroxycarboxylic acid receptor 2, was concentrated in a particular cell type already linked to seizures. The receptor was also common in immune cells called microglia that patrol and protect the brain.
The researchers’ work suggests that it may be possible to develop drugs to give patients the brain benefits of the ketogenic diet without being on the highly restrictive diet, which can come with unwanted side effects such as gastrointestinal distress. For example, the scientists’ early work in lab mice suggests that niacin – vitamin B3 – may provide at least some benefit, though more research would be needed to determine if this benefit holds true in people.
“We are now exploring how this receptor modulates brain immune responses through microglia,” Kapur said. “These studies would allow us to come up with novel therapies for drug-resistant epilepsy and potentially other disorders such as multiple sclerosis and Alzheimer’s disease.”
About UVA’s Cutting-Edge Brain Research
Finding better ways to treat epilepsy, Alzheimer’s, and other neurological diseases is a core mission of UVA’s new Paul and Diane Manning Institute of Biotechnology. That institute works together with UVA’s Brain Institute to bring top experts across UVA to speed up the transformation of basic scientific discoveries into new treatments and cures that will help patients across Virginia and around the world.
Kapur and his colleagues have published their new findings in the scientific journal Annals of Neurology. The research team consisted of Soudabeh Naderi, John Williamson, Huayu Sun, Suchitra Joshi, Rachel Jane Spera, Savaira Zaib, Supriya Sharma, Chengsan Sun, Andrey Brodovskiy, Ifrah Zawar and Kapur. The scientists have no financial interest in the work.
The research was supported by the National Institute of Health’s National Institute of Neurological Disorders and Stroke, grants R01NS120945 and R37NS119012, and the UVA Brain Institute.
To keep up with the latest medical research news from UVA, bookmark the Making of Medicine blog at https://makingofmedicine.virginia.edu.
END
(Toronto and Oslo, January 14, 2026) JMIR Publications, a leading open-access digital health research publisher, and Sikt (Norwegian Agency for Shared Services in Education and Research) are pleased to announce a new pilot partnership that brings JMIR’s Flat-Fee Unlimited Open Access Publishing model to Norway. University College of Molde (Høgskolen i Molde) is the first institution to join the trial program.
“Our partnership with Sikt is further progress in our mission to advance open science and empower researchers globally,” said Dennis O’Brien, VP ...
Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies. TNBC also is more likely to metastasize, or travel through the blood stream to spread to other organs, which causes most of breast cancer-related deaths each year. Until now, tracking circulating tumor cells (CTC), a powerful indicator of cancer metastasis, has been challenging because there are very few markers that specifically identify these cells.
Looking to find a better way to follow metastasis progression, researchers at Baylor College of Medicine developed a procedure to enhance the ...
The last time you scrubbed a streaky window or polished a porcelain appliance, you probably used a chemical called ammonia.
Also known as ammonium hydroxide when mixed with water, ammonia is more than a common household cleaner. More than 170 million metric tons of it are produced globally every year, with most of it ending up as fertilizer for corn, cotton and soybeans.
UIC researchers are scaling up a system for farmers to produce ammonia in their own backyards. The method, which uses renewable electricity and Earth’s natural resources, appears in the journal PNAS.
“So many people around the world need food. ...
The Korea Research Institute of Standards and Science (KRISS, President Lee Ho Seong) has developed a key materials technology that accelerates the commercialization of all-solid-state batteries (ASSBs)—next-generation batteries designed to intrinsically eliminate the risks of fire and explosion.
The Emerging Material Metrology Group at KRISS demonstrated ultra-dense, large-area solid electrolyte membranes by applying a method that coats solid electrolyte powders with multifunctional compounds, reducing production costs to one-tenth of conventional levels.
Lithium-ion secondary batteries, which are widely used in electric vehicles ...
Hoboken, NJ., January 12, 2026 — Disinfecting drinking water prevents the spread of deadly waterborne diseases by killing infectious agents such as bacteria, viruses and parasites. Without disinfection, even clear-looking water can carry pathogens that can cause severe and even life-threatening illness, especially in children, older adults, and people with weakened immune systems. Before water disinfection processes were put in place, outbreaks of waterborne diseases such as cholera, typhoid, and dysentery routinely claimed lives, decimating cities and even countries. Disinfecting drinking water is ...
A new study from researchers at Mass General Brigham finds that patients who undergo unscheduled or unplanned cesarean deliveries are at substantially increased risk for experiencing acute psychological stress during childbirth, with effects that can persist for months and impact maternal mental health and early bonding with infants. Results are published in Pregnancy.
The study, which followed more than 1,100 women who gave birth at Massachusetts General Hospital, a founding member of the Mass General Brigham healthcare system, found that over 1 in 4 patients who had an unscheduled cesarean delivery experienced clinically significant acute stress shortly after birth, compared with about ...
As 2026 kicks off with a wave of “future-proof your health” messaging, new research offers practical, food-first evidence on what eating for healthy aging can look like.
In an 18-week randomized crossover feeding trial in adults 65 and older, participants following two different plant-forward dietary patterns lost weight while maintaining key markers of functional independence, grip strength and chair-rise performance, alongside improvements in multiple biomarkers tied to physical and cognitive aging.1*
The ...
A new single-cell profiling technique has mapped pre-malignant gene mutations and their effects in solid tissues for the first time, in a study led by investigators at Weill Cornell Medicine and the New York Genome Center.
The research, published Dec. 31 in Cancer Discovery, demonstrates a practical method for simultaneously measuring specific DNA mutations and gene activity in thousands of individual cells from human tissue. The technique is expected to be useful for studying pre-cancerous cells and may ultimately guide early ...
Itaconate, an endogenous mitochondrial metabolite produced by the enzyme aconitate decarboxylase 1 (ACOD1), has emerged as a central regulator of inflammation, innate immunity, and cellular stress responses. In a comprehensive review published in the Journal of Intensive Medicine by Yang et al, researchers summarize the rapidly expanding field of itaconate biology—highlighting its chemical reactivity, protein modification mechanisms, and therapeutic potential across infectious, inflammatory, autoimmune, and neurodegenerative diseases.
Itaconate and its electrophilic ...
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and begins in the cells lining the pancreatic duct. Accounting for more than 90% of all pancreatic cancers, PDAC is extremely difficult to treat and has a very high mortality rate. According to the Global Cancer Observatory 2022 report, pancreatic cancer is the sixth most common cancer in Japan, with over 47,000 new cases and more than 40,000 deaths, making it the fourth leading cause of cancer-related mortality in the country.
In search of potential treatments, Ms. Mayuka Nii, a second-year doctoral ...
